NCT00399724View on ClinicalTrials.gov

A Trial Comparing Lantus Algorithms to Achieve Normal Blood Glucose Targets in Subjects With Uncontrolled Blood Sugar With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

7,376

Participants

Timeline

Start Date

March 31, 2002

Primary Completion Date

August 31, 2003

Study Completion Date

August 31, 2003

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Insulin glargine

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY